Literature DB >> 7195085

One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura.

V J Marder, J Nusbacher, F W Anderson.   

Abstract

Fourteen patients with idiopathic thrombocytopenic purpura (ITP) have been followed for one year after plasma exchange therapy. Exchange was performed prior to splenectomy in eight of nine patients with acute ITP and following splenectomy in five patients with chronic ITP. None with chronic ITP showed a response in platelet count as a result of exchange therapy. Four of the nine with acute ITP had poor responses and required splenectomy because of persistent severe thrombocytopenia. Three of these have responded completely and are in remission. One patient with acute ITP had an equivocal response, with a most recent platelet count of 93,000/microliter. The remaining four patients with acute ITP had prompt and complete responses and now have platelet counts above 100,000/microliter without steroid treatment. Although the good responses were temporally associated with the use of plasma but not albumin, the data are not sufficient to conclude that a plasma factor must be infused to obtain a satisfactory result. The overall response after one year was about that expected for acute ITP patients treated with prednisone and early splenectomy. Exchange plasmapheresis may be of value in decreasing the number of patients who require splenectomy, but a randomized, prospective study is needed to adequately assess this possibility.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195085     DOI: 10.1046/j.1537-2995.1981.21381201800.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

Review 1.  [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].

Authors:  A Böcher; F G Hagmann; H Kreiter
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Chronic idiopathic thrombocytogenic purpura.

Authors:  G F Pineo
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

3.  [Value of preoperative thrombocyte marking in patients with idiopathic thrombocytopenic purpura].

Authors:  M Gietz; W Mempel; C Clemm; E Hiller; M Heim; W Wilmanns
Journal:  Klin Wochenschr       Date:  1988-07-15

Review 4.  Immunosuppressant therapy of idiopathic thrombocytopenic purpura.

Authors:  Y S Ahn; W J Harrington; R Mylvaganam
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Plasmapheresis in clinical medicine.

Authors:  C Linker
Journal:  West J Med       Date:  1983-01

6.  Intravenous pulse methylprednisolone in chronic idiopathic thrombocytopenia.

Authors:  A Menichelli; D Del Principe; E Rezza
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

7.  Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.

Authors:  Adrian C Newland; Blanca Sánchez-González; László Rejtő; Miklos Egyed; Nataliya Romanyuk; Marie Godar; Katrien Verschueren; Domenica Gandini; Peter Ulrichts; Jon Beauchamp; Torsten Dreier; E Sally Ward; Marc Michel; Howard A Liebman; Hans de Haard; Nicolas Leupin; David J Kuter
Journal:  Am J Hematol       Date:  2019-12-10       Impact factor: 10.047

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.